Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > BIOMED > 2014 > BM3A > BM3A.42

Monitoring the efficacy of targeted therapy with in vivo fluorescence lifetime imaging

Yasaman Ardeshirpour, Victor Chernomordik, Moinuddin Hassan, Rafal Zielinski, Jaleh Shojaeian, Jacek Capala, and Amir Gandjbakhche

Not Accessible

Your library or personal account may give you access

Abstract

In this study we have shown that in-vivo fluorescence lifetime imaging can be used for monitoring the efficacy of targeted therapy with 17-DMAG on HER2 positive tumors.

© 2014 Optical Society of America

PDF Article
More Like This
Detection of Specific Binding to HER2 Receptors by in vivo Fluorescence Lifetime Imaging

Yasaman Ardeshirpour, Victor Chernomordik, Moinuddin Hassan, Rafal Zielinski, Gary Griffiths, Olga Vasalatiy, Aleksandr V. Smirnov, Jay R. Knutson, Samuel Achilefu, Jacek Capala, and Amir Gandjbakhche
BTu3A.24 Biomedical Optics (BIOMED) 2012

In Vivo Fluorescence Imaging to target HER2 Receptor

Moinuddin Hassan, Sang Bong Lee, Jason Riley, Victor Chernomordik, Jacek Capala, and Amir H. Gandjbakhche
BTuD8 Biomedical Optics (BIOMED) 2008

In vivo assessment of HER2 Receptors Expression, Using NIR Fluorescence Imaging with Affibody-DyLight Probe

Victor Chernomordik, Moinuddin Hassan, Yasaman Ardeshirpour, Rafal Zielinski, Jacek Capala, and Amir Gandjbakhche
BM2A.3 Biomedical Optics (BIOMED) 2012

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use